Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Axelsson

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Neuroinflammation|January 26, 2019
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infectionLinn Hermansson, Aylin Yilmaz, Markus Axelsson, et al.
Acta Neurologica Scandinavica|May 16, 2019
Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseasesRadu Constantinescu, Ubah Mahamud, Clara Constantinescu, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 28, 2024
Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker ReleaseAnna Corderfeldt Keiller, Markus Axelsson, Gudrun Bragadottir, et al.
Journal of the Neurological Sciences|January 26, 2024
High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple sclerosisSimone Hjæresen, Eirikur Benedikz, Tobias Sejbaek, et al.
Multiple Sclerosis and Related Disorders|April 15, 2023
Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosisLenka Novakova, Marcus Henricsson, Elias Björnson, et al.
Annals of Clinical and Translational Neurology|July 20, 2024
CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or surgeryErik Fernström, Marianne Jarfelt, Malin Blomstrand, et al.
BMC Nephrology|May 9, 2025
Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rateTorunn Axelsson, Henrik Zetterberg, Kaj Blennow, et al.
Journal of the Peripheral Nervous System : JPNS|June 8, 2023
CYBA allelic variants are associated with severity and recovery in Guillain-Barré syndromeAndreas Törnell, Nina Lagerström, Natalia Mossberg, et al.
Scientific Reports|November 23, 2019
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosisÅsa Sandelius, Sofia Sandgren, Markus Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
MS risk genes are transcriptionally regulated in CSF leukocytes at relapseMargareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Neuroinflammation|January 26, 2019
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infectionLinn Hermansson, Aylin Yilmaz, Markus Axelsson, et al.
Acta Neurologica Scandinavica|May 16, 2019
Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseasesRadu Constantinescu, Ubah Mahamud, Clara Constantinescu, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 28, 2024
Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker ReleaseAnna Corderfeldt Keiller, Markus Axelsson, Gudrun Bragadottir, et al.
Journal of the Neurological Sciences|January 26, 2024
High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple sclerosisSimone Hjæresen, Eirikur Benedikz, Tobias Sejbaek, et al.
Multiple Sclerosis and Related Disorders|April 15, 2023
Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosisLenka Novakova, Marcus Henricsson, Elias Björnson, et al.
Annals of Clinical and Translational Neurology|July 20, 2024
CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or surgeryErik Fernström, Marianne Jarfelt, Malin Blomstrand, et al.
BMC Nephrology|May 9, 2025
Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rateTorunn Axelsson, Henrik Zetterberg, Kaj Blennow, et al.
Journal of the Peripheral Nervous System : JPNS|June 8, 2023
CYBA allelic variants are associated with severity and recovery in Guillain-Barré syndromeAndreas Törnell, Nina Lagerström, Natalia Mossberg, et al.
Scientific Reports|November 23, 2019
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosisÅsa Sandelius, Sofia Sandgren, Markus Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
MS risk genes are transcriptionally regulated in CSF leukocytes at relapseMargareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Pageof 9